Nongranulomatous Iritis (Anterior Uveitis) Follow-up

Updated: May 17, 2021
  • Author: Andrew A Dahl, MD, FACS; Chief Editor: John D Sheppard, Jr, MD, MMSc  more...
  • Print

Further Outpatient Care

Patients require close follow-up care, with steroids tapered as the inflammation resolves.

Patients should be reexamined 2-3 weeks after all medications have been tapered to ensure that no residual inflammation is present.



Recurrent episodes of iritis and the subsequent therapy may lead to cataract formation and to glaucoma.



Most patients can expect to have a recurrence of iritis.

Overall, the visual prognosis for patients with recurrent iritis is good in the absence of either cataract formation or glaucoma.


Patient Education

If the patient has known or newly diagnosed HLA-B27 disease, he or she should be instructed to always keep a bottle of steroids handy. The patient should instill the steroid at the first sign of an iritis flare. The patient should come into the office as soon as possible to confirm the presence or absence of the iritis.

For patient education resources, see the Eye and Vision Center, as well as Anatomy of the Eye and Iritis.